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Many treatments have been developed for depression, 
but people are often unable to access them, and even if 
they can, the treatment may be ineffective: Even our best 
(psychological or pharmacological) are successful for 
only about 50% of depressed individuals (Hollon, Stewart, 
& Strunk, 2006). There is increasing recognition that to 
reduce the huge global burden of depression (World 
Health Organization, 2008), we need to develop interven-
tions that are not only more accessible (e.g., Internet-
delivered psychological therapies; Andersson, Riper, & 
Carlbring, 2014) but also more effective and resource effi-
cient (Kazdin & Rabbitt, 2013). A key strategy is the iden-
tification and targeting of clinical mechanisms that current 
treatments fail to improve (e.g., Insel, 2012) and greater 
personalization of treatments (e.g., Fu, Steiner, & 
Costafreda, 2013; Johansson et al., 2012; Kazdin & Blase, 
2011). Cognitive science offers one route to develop 
more effective, targeted treatment tools by identifying 
both the key cognitive mechanisms involved in the main-
tenance of a disorder and a potential means to modify 
them.
In depression, promising targets for intervention are 
offered by the cognitive biases that characterize the 
 disorder—dysfunctional patterns in interpretation, atten-
tion, and memory (e.g., Gotlib & Joormann, 2010; 
Mathews & MacLeod, 2005). These have been the target 
of cognitive-training paradigms referred to as cognitive 
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Abstract
Depression is a global health problem requiring treatment innovation. Targeting neglected cognitive aspects may 
provide a useful route. We tested a cognitive-training paradigm using positive mental imagery (imagery cognitive bias 
modification, imagery CBM), developed via experimental psychopathology studies, in a randomized controlled trial. 
Training was delivered via the Internet to 150 individuals with current major depression. Unexpectedly, there was no 
significant advantage for imagery CBM compared with a closely matched control for depression symptoms as a whole 
in the full sample. In exploratory analyses, compared with the control, imagery CBM significantly improved anhedonia 
over the intervention and improved depression symptoms as a whole for those participants with fewer than five episodes 
of depression and those who engaged to a threshold level of imagery. Results suggest avenues for improving imagery 
CBM to inform low-intensity treatment tools for depression. Anhedonia may be a useful treatment target for future work.
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bias modification (CBM), which aim to retrain dysfunc-
tional biases and thus improve symptoms (Koster, Fox, & 
MacLeod, 2009). Although in its early stages, interest in 
clinical applications of CBM paradigms has accelerated in 
recent years, with new domains of disorder and popula-
tions coming under investigation (Lau, 2013; Woud & 
Becker, 2014).
We have developed a specific CBM paradigm as a 
potential treatment tool or adjunct for use in depression 
that focuses on two cognitive targets: mental imagery and 
interpretation. This “imagery CBM” involves repeated 
practice in generating positive resolutions via mental 
imagery when confronted with ambiguous stimuli, with 
the aim of instilling a more adaptive bias to automatically 
imagine positive resolutions of novel ambiguous infor-
mation in everyday life (e.g., Holmes, Mathews, Dalgleish, 
& Mackintosh, 2006; Holmes, Mathews, Mackintosh, & 
Dalgleish, 2008). The paradigm emerged from the experi-
mental literature on modification of negative interpretive 
biases (Mathews & Mackintosh, 2000), and in its develop-
ment for depression, there has been increasing emphasis 
on the mental imagery component (Holmes, Lang, & 
Deeprose, 2009). Depression has been associated with a 
deficit in positive future imagery (Holmes, Lang, Moulds, 
& Steele, 2008; Morina, Deeprose, Pusowski, Schmid, & 
Holmes, 2011). Thus, depressed individuals may particu-
larly benefit from the repeated practice in generating 
positive mental images that is encouraged by imagery 
CBM. Furthermore, mental imagery has been relatively 
neglected in depression and, thus, may provide a new 
and promising avenue for treatment development 
(Weßlau & Steil, 2014).
A series of experimental studies with healthy partici-
pants (Holmes, Coughtrey, & Connor, 2008; Holmes 
et  al., 2006; Holmes, Lang, & Shah, 2009; Holmes & 
Mathews, 2005; Nelis, Vanbrabant, Holmes, & Raes, 2012) 
and dysphoric individuals (Pictet, Coughtrey, Mathews, & 
Holmes, 2011) established the effects of imagery CBM in 
modifying interpretive bias and increasing positive affect 
in the laboratory. Furthermore, they demonstrated the 
importance of the instructions to use mental imagery (as 
opposed to verbal processing) for these effects. A single 
case series of imagery CBM completed daily for 1 week 
by seven depressed participants in their own homes pro-
vided initial evidence of clinical efficacy in reducing 
symptoms of depression (Blackwell & Holmes, 2010). 
Two subsequent preliminary randomized clinical studies 
(n = 13 per condition, again home-based) demonstrated 
a greater reduction in symptoms of depression when 
imagery CBM was compared with a control condition 
(Lang, Blackwell, Harmer, Davison, & Holmes, 2012; 
Torkan et  al., 2014). Williams, Blackwell, Mackenzie, 
Holmes, and Andrews (2013) investigated a combination 
therapy of imagery CBM, delivered via the Internet, 
followed by Internet-based cognitive behavior therapy 
(iCBT). The combined intervention (n = 38) was com-
pared with a wait list (n = 31) and showed a significant 
benefit on symptoms of depression after both the imag-
ery CBM and the iCBT components.
Our aim in the current study was to build on these 
results and further develop imagery CBM “from the lab 
toward the clinic” as a potential low-intensity treatment 
tool for depression. We extended the cognitive-training 
schedule from 1 to 4 weeks, doubling the number of 
training sessions completed at home from 6 to 12, and 
developed an Internet-delivered version. We also 
extended the follow-up from 2 weeks to 6 months. We 
aimed to recruit a larger sample of participants with cur-
rent major depression than used in previous studies, and 
to carry out the study within the more rigorous evaluative 
framework of a randomized controlled trial (RCT) to test 
the potential clinical efficacy of the imagery CBM in 
reducing symptoms of depression.
The trial also allowed us to examine mechanisms such 
as specific cognitive processes and symptoms influenced 
by imagery CBM. For example, the positive mental imag-
ery aspect of the intervention suggests one potential clin-
ical target that had previously not been explored: 
anhedonia. Anhedonia, the loss of interest in or enjoy-
ment from activities, constitutes, alongside depressed 
mood itself, one of the two core diagnostic features of 
depression (American Psychiatric Association, 2013). 
However, anhedonia does not respond well to current 
first-line treatments (pharmacological or psychological) 
and is predictive of poorer treatment outcomes (Treadway 
& Zald, 2011; Uher et al., 2012). Imagery CBM involves 
repeatedly imagining oneself engaging in a broad range 
of activities that resolve with positive outcomes (e.g., 
going to work, meeting a friend, getting up in the morn-
ing). Many of the training scenarios specify one or more 
positive emotions to be imagined, for example, enjoy-
ment, pleasure, interest, or excitement. The repeated 
practice in imagining, enjoying, and gaining pleasure 
from activities during the imagery CBM may therefore 
lead to an increased ability to anticipate positive emo-
tional outcomes from activities in daily life, something 
that may be particularly problematic in depression (Dunn, 
2012; Sherdell, Waugh, & Gotlib, 2012).
Early indicators of how to match patients to treat-
ments, or patient stratification (Fu et al., 2013), are also 
important in development of experimental treatments. 
Potential treatment responders may be identified as fall-
ing into a particular clinical subgroup, or, alternatively, 
there may be more subtle indicators of patient engage-
ment with the intervention that may be identifiable, such 
as early performance on a task (e.g., Clarke, Chen, & 
Guastella, 2012; Eberl et al., 2013). There may be large 
variation in treatment adherence and fidelity in 
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Internet-delivered interventions (cf. Christensen, Griffiths, 
& Farrer, 2009), and studies have been criticized for the 
failure to investigate this (Kiluk et al., 2011). We therefore 
sought to assess such aspects in the current study.
This article first focuses on the main outcome of the 
trial, change in symptoms of depression, and then 
addresses other outcome and process variables relevant 
to understanding the transition from experimental psy-
chopathology research to a clinical trials framework. Our 
primary hypothesis1 was that participants who completed 
the imagery CBM intervention (imagery condition) would 
demonstrate a greater decrease in symptoms of depres-
sion during the 4 weeks from baseline to posttreatment 
than would participants completing a closely matched 
(i.e., active) control version of the program (control con-
dition). Secondary hypotheses were that there would be 
greater improvements in cognitive targets from baseline 
to posttreatment and that improvements would be main-
tained at 1-, 3-, and 6-month follow-up. Consistent with 
our interest in positive imagery and emotion, in further 
exploratory analyses we investigated the effect of imag-
ery CBM on anhedonia. We also examined for whom (on 
the basis of baseline measures) the imagery CBM may be 
more effective and the role of active engagement in the 
training on outcomes.
Method
Study design and participants
We conducted an RCT with two parallel groups. 
Recruitment was via advertisement in local media (news-
papers, radio), Web sites (e.g., Google, Facebook), and 
community, university, and health settings in the local 
area.
Eligible participants were those aged 18 to 65 who 
were fluent in written and spoken English and who met 
Diagnostic and Statistical Manual of Mental Disorders 
(4th ed., text rev.; American Psychiatric Association, 2000) 
criteria for a current major depressive episode assessed 
via a semi-structured clinical interview (the Structured 
Clinical Interview for DSM–IV–TR Axis I Disorders, SCID; 
First, Spitzer, Gibbon, & Williams, 2002). In addition, par-
ticipants had to be able to give informed consent, to 
access the Internet-based intervention, and to attend the 
research center for assessment appointments. We 
excluded participants who met criteria for a current psy-
chotic or substance-abuse disorder, had a history of 
mania or hypomania, had started or changed dose of 
antidepressant medication during the past month, were 
currently receiving psychological therapy, or were 
involved in other current treatment trials.
Entrance to the trial was via self-referral. On contact-
ing the research team, potential participants completed a 
set of screening questionnaires, including demographics 
and the Beck Depression Inventory–II (BDI-II; Beck, 
Steer, & Brown, 1996), via the study Web site. Participants 
scoring 14 or above on the BDI-II were invited for the 
eligibility assessment. In July 2012, we amended the pro-
tocol to include a brief structured telephone screening 
interview for all participants who scored 14 or above on 
the BDI-II, which was designed to screen out those par-
ticipants who obviously met exclusion criteria.
The eligibility assessment took place at the research 
center. Participants gave written informed consent, after 
which a researcher conducted the SCID interview and 
collected information about current and past treatments 
for mental health. Ineligible participants were debriefed 
and provided with information about accessing local 
mental-health services, if appropriate. Eligible partici-
pants were invited to return for a face-to-face baseline 
assessment at the research center (see the Trial Sites and 
Approvals section in the appendix).
Ethical approval was provided by the National 
Research Ethics Service (NRES) Committee South Central–
Oxford C (11/SC/0278). The study was prospectively reg-
istered (clinicaltrials.gov identifier NCT01443234).
Intervention
The imagery CBM intervention comprised 12 sessions 
completed at home via the study Web site during a 
4-week period. Six sessions were in an auditory form in 
which participants listened to audio recordings of 
descriptions of everyday situations (approximately 10 s 
each) and were instructed to imagine themselves in the 
scenarios “as if actively involved, seeing them through 
your own eyes” (Holmes et  al., 2006). As in previous 
studies, the descriptions were initially ambiguous as to 
their resolution but always ended positively. The other 6 
sessions used stimuli in a picture-word form in which 
participants were presented with ambiguous photos of 
mostly everyday scenes paired with a caption of a few 
words that resolved the ambiguity in a positive way 
(Holmes, Mathews, et  al., 2008; Pictet et  al., 2011). 
Participants were instructed to generate a mental image 
combining the picture and the words.
Each of the 12 sessions started with reminder instruc-
tions and a practice example followed by 64 training 
stimuli arranged into eight sets of 8 with a self-paced 
break in between each set (cf. Blackwell & Holmes, 2010; 
Lang et al., 2012). After each stimulus, participants were 
asked, “How vividly could you imagine the scenario 
described?” Responses were made on a scale from 1 (not 
at all vivid) to 5 (extremely vivid). No individual training 
stimulus was repeated, so that during the course of the 
study (12 sessions at home plus the practice session), 
participants were presented with 416 unique auditory 
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stimuli and 416 unique picture-word stimuli. Participants 
were scheduled to complete a session of the CBM every 
day during the 1st week, starting with an auditory session 
and then alternating between this and the picture-word 
paradigm, and then 2 sessions in each of the following 3 
weeks (1 session of each paradigm). The scheduled order 
of sessions was the same for all participants. Participants 
were able to exit a session and resume it at a later time if 
necessary. If a participant missed completing a session 
on the scheduled date, the session remained available to 
complete on a later date.
The intervention in the control condition was identical 
in all but the following aspects. First, we aimed to remove 
the training contingency between ambiguity and positive 
resolution (following Lang et al., 2012). To this end, half 
of the auditory training scenarios resolved positively and 
half resolved negatively. Similarly, half of the pictures had 
positive captions and half had negative captions. Second, 
we aimed to remove the mental imagery component of 
the training. To this end, in the auditory paradigm, partici-
pants were asked to “focus on the words and meanings” 
of the training scenarios and after each scenario were 
asked, “How difficult was it to understand the meaning of 
the description?” In the picture-word paradigm, partici-
pants were instructed to generate a sentence combining 
the picture and word, and after each picture-word combi-
nation they were asked, “How difficult was it to make a 
sentence combining the picture with the words?” For both 
paradigms, responses were made on a scale from 1 (not 
at all difficult) to 5 (extremely difficult).
The computer system for delivering the interventions 
via the Internet was built using model-driven tools devel-
oped at the University of Oxford’s Department of 
Computer Science (Davies, Gibbons, Welch, & Crichton, 
2014). Participants accessed the intervention from the 
study Web site using their Web browser, and the HTML 
interfaces were implemented using Java Server Pages and 
JavaScript technology. The system was deployed on a 
secure Web server located in a server room with restricted 
physical access. Login to the server itself was only 
through secure channels to a small number of known 
system administrators. Participants accessed the Web site 
through an encrypted hypertext transfer protocol secure 
(https) protocol.
Measures
Clinical history and baseline characteristics. Clini-
cal information, such as anxiety comorbidities and self-
reported number of previous episodes of depression, 
was collected during the SCID interview. Baseline mea-
sures included everyday use of imagery (Spontaneous 
Use of Imagery Scale, SUIS; Reisberg, Pearson, & Kosslyn, 
2003), trait anxiety (Trait scale from the State-Trait Anxiety 
Inventory; Spielberger, Gorsuch, Lushene, Vagg, & 
Jacobs, 1983), and quality of life (EuroQol-5D-3L, EQ5D; 
Kind, 1996).
Primary outcome of the RCT. The primary outcome 
measure, as specified in the trial registration, was change 
in BDI-II score during the 4 weeks from baseline to post-
treatment assessment. The BDI-II is a widely used mea-
sure of depressive symptoms with scores classified as 
follows: 0 to 13, minimal depression; 14 to 19, mild 
depression; 20 to 28, moderate depression; 29 to 63, 
severe depression. The BDI-II has good psychometric 
properties whether administered on paper or online 
 (Holländare, Andersson, & Engström, 2010). The anhedo-
nia items on the BDI-II (Item 4: loss of pleasure; Item 12: 
loss of interest) were summed as in Davidson et al. (2010).
Process and mechanisms measures: cognitive tar-
gets, in-session vividness/difficulty ratings, and 
fidelity ratings. Negative interpretive bias was assessed 
via the Scrambled Sentences Test (SST; Rude et al., 2002) 
administered under cognitive load (remembering a six-
digit number). Participants unscrambled a list of 20 
scrambled sentences (e.g., winner born I am loser a) with 
a time limit of 4 min (as in Blackwell & Holmes, 2010; 
Lang et al., 2012). A “negativity” score was generated by 
calculating the proportion of sentences completed cor-
rectly with a negative emotional valence (e.g., I am a 
born loser). Two sets of sentences (baseline and post-
treatment) were counterbalanced.
Vividness of positive future imagery was measured via 
the Prospective Imagery Test (PIT; Stöber, 2000). 
Participants generated a mental image of 10 positive and 
10 negative possible future scenarios and rated each on a 
5-point scale for vividness (responses ranged from 1, no 
image at all, to 5, very vivid), perceived likelihood of the 
event happening in the near future (responses ranged 
from 1, not at all likely to occur, to 5, extremely likely to 
occur), and sense of “preexperiencing” of the event 
(responses ranged from 1, not at all, to 5, completely; cf. 
Blackwell et al., 2013).
As described earlier, after each of the training stimuli 
presented during the Internet intervention, participants 
gave a rating of vividness (imagery condition) or diffi-
culty (control condition). During each session, the ratings 
were saved to the server at the end of each block of eight 
scenarios. For each participant, a grand mean vividness/
difficulty rating for the 12-session intervention (i.e., 768 
training stimuli) was calculated by averaging the avail-
able block means.
At posttreatment, participants completed ratings of 
their engagement with the intervention during the 4 
weeks, which provided a measure of the fidelity with 
which they had adhered to the experimental 
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manipulation (imagery or verbal processing). These 
included ratings of use of imagery—“How much did you 
find yourself thinking in images (i.e., in mental pictures 
and sensory impressions) as you were listening to the 
scenarios?” and “How much did you find yourself think-
ing in images (i.e., in mental pictures and sensory impres-
sions) about the picture-word combinations?”—and use 
of verbal processing, “How much did you find yourself 
verbally analysing the meaning of the scenarios as you 
were listening to them?” and “How much did you find 
yourself thinking verbally (i.e., in words and making sen-
tences) about the picture-word combinations?” All 
responses were made on a scale from 1 (not at all) to 9 
(all of the time).
Assessment of expectancy and satisfaction. Expec-
tancy was measured at baseline to demonstrate equiva-
lence across conditions. The three expectancy questions 
from the Credibility and Expectancy Questionnaire 
 (Devilly & Borkovec, 2000) were adapted for the current 
study. An expectancy score is derived by first standard-
izing the three individual item scores (across the whole 
sample) and then summing these three standardized 
scores (Devilly & Borkovec, 2000).
During the telephone feedback interview at 6-month 
follow-up, participants gave numerical ratings to the fol-
lowing three questions about their experience of the 
online intervention: “If you had been offered this online 
program as a treatment option by your GP or another 
health professional, how satisfied would you be with 
what you received?” (rated from 1, extremely dissatisfied, 
to 7, extremely satisfied); “How confident would you be 
about recommending this program to a friend with 
depression?” (rated from 1, extremely unconfident, to 7, 
extremely confident); and “If you were feeling depressed 
or down in the future, would you be willing to try this 
program again?” (rated from 1, extremely unlikely, to 7, 
extremely likely would try again).
Procedure
At the baseline assessment, after completion of baseline 
questionnaire measures and random allocation to condi-
tion (for details, see the Randomization section in the 
appendix), participants completed the SST. A researcher 
gave a brief overview of the participant’s allocated inter-
vention, after which the participant completed the 
Expectancy Questionnaire. The researcher then adminis-
tered a standardized brief (approximately 15-min) intro-
duction to the intervention. In the imagery condition, this 
included an introduction to mental imagery and practice 
in generating mental imagery, as in previous studies (e.g., 
Holmes et  al., 2006). The introduction for the control 
condition was matched in structure and included an 
introduction to verbal processing and practice in verbal 
processing adapted from previous experimental studies 
(e.g., Holmes et al., 2006). Participants then completed a 
practice session of their allocated intervention, with guid-
ance from the researcher. This consisted of four sets of 
auditory stimuli and four sets of picture-word stimuli. To 
increase adherence, at the end of this session, the 
researcher helped participants to plan when they would 
complete intervention sessions during the next 4 weeks 
and explained that completing the sessions in the way 
instructed may help to improve their mood (following 
Blackwell & Holmes, 2010; Lang et al., 2012).
A researcher monitored the participant during the sub-
sequent 4 weeks while he/she completed the online 
intervention from home and sent e-mails to remind the 
participant about each upcoming session and thank them 
for each session completed. If a participant missed ses-
sions and did not respond to e-mail contact, phone con-
tact was attempted to promote adherence. Researchers 
followed a written protocol containing e-mail templates 
to standardize this contact across participants. A written 
log of all e-mails, phone calls, and voice mail messages 
was kept to verify equivalent contact across conditions.
Participants attended a posttreatment assessment 
approximately 4 weeks after the baseline assessment. 
After completion of outcome measures, which were 
administered by a researcher blind to participant alloca-
tion (for details, see the Blinding section in the appen-
dix), participants completed the fidelity ratings and a 
feedback interview. If participants became unable to 
attend the posttreatment assessment, questionnaire out-
come measures were completed online (n = 8) or by mail 
(n = 7).
At 1, 3, and 6 months after the end of the 4-week inter-
vention, participants completed follow-up questionnaires 
online. After participants completed the 6-month ques-
tionnaires, they were contacted by phone, and a final 
feedback interview and debriefing were conducted. If 
participants did not complete the online questionnaires 
after receiving reminders, they were mailed a paper copy 
of the BDI-II with a prepaid return envelope to maximize 
return of the primary outcome measure.
Participants received reimbursement for their time of 
30 pounds ($45) after the posttreatment assessment and 
a further 10 pounds ($15) on completion of the 6-month 
follow-up questionnaires. Participants could additionally 
be reimbursed travel costs for attending the face-to-face 
assessment sessions.
Statistical analysis
A sample-size calculation (G*Power 3.1.7; Faul, Erdfelder, 
Lang, & Buchner, 2007) showed that 128 participants 
would be needed to provide 80% power to detect a 
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difference of 0.5 (medium effect size d) between the two 
groups on the primary outcome at a 5% significance 
level, two-tailed. We used 0.5 as a conservative estimate 
of effect size over 4 weeks following an intention-to-treat 
analysis of the data from Lang et  al. (2012), which 
obtained a between-groups effect size of 0.67 for the 
BDI-II for change from baseline to follow-up during a 
period of 3 weeks. We aimed to recruit 150 participants 
in total to allow for up to 15% attrition at the primary end 
point (posttreatment). The main efficacy analyses were 
carried out in SPSS Version 21 by a statistician (P.W.) not 
involved in data collection and blind to participant allo-
cation and, according to a predefined analysis plan 
reviewed by a second statistician, not otherwise involved 
in the trial. Further analyses were carried out by P.W. and 
S.E.B. using SPSS Version 22.
Main efficacy analyses. Primary comparative analy-
ses between the two groups were conducted by intention 
to treat, performed as mixed-model repeated measures 
analysis of variance (ANOVA) with time as within-groups 
factor and condition as between-groups factor, using the 
SPSS MIXED command. Mixed-model repeated measures 
uses all available data with no imputation of missing val-
ues, which are assumed to be missing at random, and it 
is able to fit a general correlation structure between the 
time points (i.e., no sphericity assumption). Mixed mod-
els have been recommended for analyses of trial data 
(Gueorguieva & Krystal, 2004). A two-level multilevel 
model was fitted, with an unstructured covariance matrix 
(Heck, Thomas, & Tabata, 2010). The stratification vari-
ables were included as covariates. Estimated mean 
changes within each group over time, planned contrasts, 
effect sizes (expressed as Cohen’s d), and confidence 
intervals (CIs) were derived from the mixed-modeling 
analysis.2 Treatment groups were tested at the two-sided 
5% significance level. The mixed model was fitted over 
all five assessment time points and, thus, the comparison 
between conditions of change from baseline to posttreat-
ment was given by the estimate for this fixed effect 
(expressed as a t statistic) from the mixed model (i.e., as 
opposed to conducting separate mixed-models analyses 
to test hypotheses about change from baseline to post-
treatment and from baseline to follow-up). The Time × 
Condition interaction over all five time points therefore 
gave an estimate of the difference between the patterns 
of change during the 7 months of assessment between 
the two conditions and, thus, additionally indicated 
potential maintenance of benefits during the 6-month 
follow-up period.
Secondary analyses were also conducted on a “per-
protocol” population described in the prespecified statis-
tical analysis plan as those participants judged to have 
received an adequate “dose” of the intervention, which 
was defined as more than six sessions completed (i.e., 
the dose investigated in previous studies; Blackwell & 
Holmes, 2010; Lang et al., 2012), and who had completed 
the outcome data within sufficient time of the scheduled 
date of the assessment to meaningfully relate to that time 
point: within 2 weeks for the posttreatment assessment 
and 1-month assessment; within 1 month for the 3-month 
assessment; and within 2 months for the 6-month assess-
ment. The per-protocol analyses were carried out as for 
the primary efficacy analyses using mixed-model 
ANOVAs.
We used a stringent “recovery” criterion to calculate 
proportions of individuals in each condition who demon-
strated “clinically significant change” from baseline on 
the BDI-II at each time point. Clinically significant change 
was defined as a reduction in score greater than a reli-
able change index of 6.90 ( Jacobson & Truax, 1991), cal-
culated using the pretreatment standard deviation in our 
sample and the test-retest reliability from standardization 
data (r = .93), and meeting criteria for recovery (BDI-II 
score less than 14; Beck et al., 1996). Participants with 
missing data at the relevant time point in the intention-to-
treat sample were classed as “not recovered.”
Further process and mechanisms analyses. We car-
ried out analyses of potential subgroup or moderating 
variables within the same analytic framework as for our 
main efficacy analyses (i.e., mixed-model repeated mea-
sures ANOVAs with time as within-groups factor and con-
dition as between-groups factor, using the SPSS MIXED 
command and including the stratifying variables as 
covariates). A subgroup/moderating variable of interest 
was included in the mixed model as a main effect, two-
way interaction terms of Moderator × Condition and 
Moderator × Time, and a three-way interaction term of 
Moderator × Condition × Time. A potential moderating 
effect is indicated by the three-way interaction between 
the variable of interest, condition, and time (Sun et al., 
2012). Where appropriate, moderating effects were inves-
tigated within condition via the same mixed model but 
with the condition term and its interactions omitted.
Results
Participants were recruited from February 2012 to 
February 2013. Follow-up was completed by November 
2013. Recruitment stopped at 150 participants, which was 
the planned target. Of 252 people assessed for eligibility, 
74 did not meet the inclusion criteria, 28 met inclusion 
criteria but dropped out prior to randomization, and 150 
were randomized (see Fig. 1). Overall, 141 (94%) partici-
pants completed at least the BDI-II postintervention (pri-
mary outcome), and 140 (93%), 129 (86%), and 133 (89%) 
completed at least this outcome measure at 1-, 3-, and 
Positive Imagery-Based Cognitive-Bias Modification for Depression 97
Table 1. Characteristics of Participants Allocated to Either the Imagery Cognitive Bias Modification or the 
Control Condition
Characteristic Imagery (n = 76) Control (n = 74)
Womena 52 (68%) 51 (69%)
Age (years) 37.64 (14.10) 33.28 (13.73)
BDI-II score by categorya  
 0–28 35 (46%) 32 (43%)
 ≥ 29 41 (54%) 42 (57%)
White 73 (96%) 69 (93%)
Marital status  
 Married or cohabiting 33 (43%) 23 (31%)
 Single 30 (40%) 42 (57%)
 Separated, divorced, or widowed 13 (17%) 9 (12%)
Employment status  
 In paid employment (full-time or part-time) 46 (61%) 39 (53%)
 Student 18 (24%) 24 (32%)
 Not in employment 12 (16%) 11 (15%)
Housing status  
 Home owner 28 (37%) 22 (30%)
 Tenant 29 (38%) 30 (41%)
 University accommodation 13 (17%) 13 (18%)
 Otherb 6 (8%) 9 (12%)
Years of education  
 ≤ 11 5 (7%) 6 (8%)
 12–15 24 (32%) 19 (26%)
 ≥ 16 47 (62%) 49 (66%)
Hours of Internet use per week 20.74 (13.76) 21.30 (12.04)
Duration of current episode of depression (months)  
 ≤ 3 39 (51%) 39 (53%)
 4–6 12 (16%) 11 (15%)
 7–12 9 (12%) 11 (15%)
 > 12 16 (21%) 13 (18%)
Number of previous episodes of depression  
 0–1 19 (25%) 18 (24%)
 2–3 20 (26%) 13 (18%)
 ≥ 4 37 (49%) 43 (58%)
Age of onset of depression 21.36 (10.20) 20.31 (10.83)
Current comorbid anxiety disorder 42 (55%) 40 (54%)
Current treatment with antidepressants 33 (43%) 31 (42%)
Ever treated with antidepressants 53 (70%) 52 (70%)
Reported history of psychological therapy/counselling 51 (67%) 41 (55%)
Ever spoken to a health professional about mood 71 (93%) 62 (84%)
Currently have contact with a health professional about mood 23 (30%) 25 (34%)
How heard about studyc  
 Poster advert 5 (7%) 11 (15%)
 Radio/newspaper advertisement 22 (29%) 17 (23%)
 Internet 32 (43%) 28 (38%)
 Otherd 16 (21%) 18 (24%)
Baseline scores  
 BDI-II 29.96 (8.63) 31.14 (10.17)
 STAIT 61.00 (6.33) 61.59 (6.87)
 EQ5D 61.38 (20.17) 58.88 (18.91)
 SUIS 38.50 (9.90) 40.34 (7.91)
(Continued)
98 Blackwell et al.
6-month follow-up, respectively. Attrition was compara-
ble between the two conditions (see Fig. 1), as were 
baseline characteristics (see Table 1). Participants in the 
control condition scored significantly higher at baseline 
than did those in the imagery condition on vividness of 
negative future imagery (PIT negative vividness), t(148) = 
2.58, p = .011, d = 0.42.
Adherence and fidelity
Adherence rates to the online program were good and 
comparable across conditions; 67 participants (88%) 
completed more than 6 of the 12 intervention sessions 
(i.e., completed the intervention per protocol) in the 
imagery condition versus 69 (93%) in the control condi-
tion. There was no difference between the two condi-
tions in number of sessions completed (Mimagery = 10.37, 
SD = 2.95; Mcontrol = 11.00, SD = 2.29), t(148) = 1.46, p = 
.15. Participants in the imagery condition reported using 
imagery significantly more in the intervention sessions 
than did participants in the control condition (Mimagery = 
7.17, SD = 1.04; Mcontrol = 4.14, SD = 1.70), t(131) = 12.45, 
p < .001, d = 2.16. Participants in the imagery condition 
reported using verbal analysis significantly less in the 
intervention sessions than did participants in the control 
condition (Mimagery = 3.38, SD = 1.59; Mcontrol = 6.43, SD = 
1.73), t(131) = 10.58, p < .001, d = 1.84. While completing 
the intervention, participants in the imagery and control 
condition received a comparable number of e-mails, 
phone calls, and voicemails from the researchers (ps > 
.12; see the Participant Contact During the Intervention 
section in the appendix for details).
Main efficacy analyses
Intention to treat. There was no significant difference 
between the two conditions in change in BDI-II scores 
from baseline to posttreatment (our primary outcome), 
t(141.11) = 0.21, p = .83, d = 0.04, 95% CI = [–0.29, 0.36] 
(see Fig. 2). For the overall mixed model (over five time 
points), there was a main effect of time, F(4, 132.34) = 
37.55, p < .001, which indicated a decrease in BDI-II 
scores over the five time points, and no significant effect 
of condition, F(1, 142.76) < 1. The overall interaction of 
condition and time was nonsignificant, F(4, 132.34) < 1. 
Within-groups effect sizes for change from baseline (d) 
ranged from 0.83, 95% CI = [0.54, 1.13], at posttreatment 
to 1.45 [1.07, 1.83] at 6-month follow-up in the imagery 
condition and from 0.74 [0.46, 1.03] at posttreatment to 
1.26 [0.89, 1.62] at 6-month follow-up in the control 
condition. Between-groups effect sizes for change from 
baseline (d) during the follow-up period ranged from 
0.07 [–0.25, 0.40] at 1-month follow-up to 0.02 [–0.31, 
0.35] at 6-month follow-up. Table S1 in the Supplemental 
Material available online provides estimated marginal 
means and effect sizes derived from the mixed-model 
analysis of BDI-II over the five study time points.
The analyses of our cognitive targets (SST, PIT posi-
tive vividness) showed a similar pattern (see Table S2 in 
the Supplemental Material). For the SST (baseline and 
posttreatment only), there was a main effect of time, 
F(1, 133.61) = 34.16, p < .001, thereby indicating a 
decrease in scores from baseline to posttreatment, but 
not condition, F(1, 145.13) < 1, and there was no Time × 
Condition interaction, F(1, 133.49) < 1, d = 0.05, 95% 
CI = [–0.29, 0.39]. For PIT positive vividness, there was 
Characteristic Imagery (n = 76) Control (n = 74)
 PIT  
  Positive vividness 2.82 (0.88) 2.87 (0.81)
  Positive likelihood 2.54 (0.64) 2.52 (0.66)
  Positive experiencing 2.62 (0.81) 2.46 (0.79)
  Negative vividness 3.16 (0.89) 3.52 (0.80)
  Negative likelihood 3.14 (0.64) 3.30 (0.62)
  Negative experiencing 3.09 (0.88) 3.13 (0.74)
 SST negativity 0.57 (0.23) 0.60 (0.24)
 Anhedonia 3.18 (1.36) 3.47 (1.36)
 Expectancy Questionnaire 0.01 (2.59) –0.01 (2.91)
Note: The table presents number (percentage) or mean (standard deviation) for each measure. BDI-II = Beck Depression 
Inventory–II (Beck et al., 1996); STAIT = Trait scale of State-Trait Anxiety Inventory (Spielberger et al., 1983); SUIS = 
Spontaneous Use of Imagery Scale (Reisberg et al., 2003); EQ5D = EuroQol-5D-3L (Kind, 1996); PIT = Prospective 
Imagery Test (Stöber, 2000); SST = Scrambled Sentences Test (Rude et al., 2002); Anhedonia = Anhedonia items from 
BDI-II (note n = 73 in control condition).
aStratification variables.
bLiving with friends or relatives, or other.
cn = 75 in the imagery condition.
dOther refers to via university e-mail list, from a friend, unsure, other.
Table 1. (continued)
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Enrolment
Assessed for eligibility (n = 252)
Excluded (n = 102)
•    Not meeting inclusion criteria (n = 74)
o    Did not meet criteria for current major depressive
      episode (n = 51)
o    History of mania/hypomania (n = 12)
o    Current substance abuse disorder (n = 6)
o    Currently receiving psychological therapy (n = 2)
o    Not able to travel to research centre for assessment
      appointments (n = 2)
o    Antidepressant medication begun or changed in
      adosage during last month (n = 1)
•    Eligible but declined to continue or lost contact
    (n = 28) 
Analyzed (n = 76)
•   Post-treatment assessment:
o   n = 72 completed at least BDI-II
o   n = 64 completed all measures per protocol
•   One-month follow-up:
o   n = 71 completed at least BDI-II
o   n = 64 completed all measures per protocol
•   Three-month follow-up:
o   n = 66 completed at least BDI-II
o   n = 65 completed all measures per protocol
•   Six-month follow-up:
o   n = 69 completed at least BDI-II
o   n = 65 completed all measures per protocol
o   n = 62 provided final feedback
•   Discontinued (n = 2)
o   No longer wished/unable to continue (n =2)
Allocated to control condition (n = 74)
•    Completed intervention as defined per 
    (protocol (n = 69)
•   Did not complete intervention as
    defined per protocol (n = 5)
o   Practical reasons (e.g. lack of time)
      (n = 3)
o   Found sessions difficult (n = 1)
o   Unknown (n = 1)
Allocation
Randomized (n = 150)
•   Post-treatment assessment:
o   n = 69 completed at least BDI-II
o   n = 61 completed all measures per 
protocol
•   One-month follow-up:
o   n = 69 completed at least BDI-II
o   n = 64 completed all measures per 
protocol
•   Three-month follow-up:
o   n = 63 completed at least BDI-II
o   n = 62 completed all measures per 
protocol
•   Six-month follow-up:
o   n = 64 completed at least BDI-II
o   n = 61 completed all measures per 
protocol
o   n = 62 provided final feedback
•   Discontinued (n = 0)
Analyzed (n = 74)
Allocated to imagery condition (n = 76)
•    Completed intervention as defined per 
    protocol (n = 67)
•    Did not complete intervention
    as defined per protocol (n = 9)
o   Practical reasons (e.g. lack of time) (n = 6)
o   Technical difficulties with computer program 
      (n = 2)
o   Unknown (n = 1)
Follow-up
Analysis
Fig. 1. Flow of participants through the trial. BDI-II = Beck Depression Inventory–II.
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a nonsignificant trend for a greater increase in the imag-
ery condition compared with the control condition from 
baseline to posttreatment, t(142.57) = 1.86, p = .065, d = 
0.31, 95% CI = [–0.02, 0.64]. In the overall mixed model 
over all 5 time points, there was a main effect of time, 
F(4, 130.90) = 6.81, p < .001, which indicated an increase 
in vividness scores over time, and no main effect of con-
dition, F(1, 143.72) = 1.46, p = .23. The overall interaction 
of condition and time was nonsignificant, F(4, 130.90) = 
1.28, p = .28.
Fig. 2. Results: Graphs show (a) primary efficacy analyses (BDI-II, intention to treat), (b) analysis of anhedonia, (c) change in BDI-II in the sub-
group of participants with fewer than five depressive episodes, and (d) illustration of change in BDI-II in participants who scored above a “vividness 
threshold” in the imagery condition (n = 27) with the control condition as comparison. Estimated marginal means from the mixed-model analysis 
are displayed. Error bars represent 1 SE. BDI-II = Beck Depression Inventory–II; CBM = cognitive bias modification.
Positive Imagery-Based Cognitive-Bias Modification for Depression 101
Per protocol. The analysis in the per-protocol sample 
(n = 115) yielded a similar pattern of results. There was 
no significant difference between the two conditions in 
change in BDI-II from baseline to posttreatment, t(113) = 
1.02, p = .31, d = 0.19, 95% CI = [–0.17, 0.56]. In the over-
all model over five time points, there was a main effect of 
time, F(4, 113) = 34.05, p < .001, thereby indicating a 
decrease in BDI-II scores over time, and no main effect 
of condition, F(1, 111.66) = 1.20, p = .28. The overall 
interaction of condition and time was nonsignificant, F(4, 
113) < 1 (see Table S1 in the Supplemental Material). 
Within-groups effect sizes for change from baseline (d) 
ranged from 0.98, 95% CI = [0.62, 1.34], at posttreatment 
to 1.58 [1.13, 2.03] at 6-month follow-up in the imagery 
condition and from 0.65 [0.34, 0.95] at posttreatment to 
1.23 [0.83, 1.63] at 6-month follow-up in the control con-
dition. Between-groups effect sizes for change from base-
line (d) during the follow-up period ranged from 0.20 
[–0.17, 0.56] at 1-month follow-up to 0.10 [–0.26, 0.47] at 
6-month follow-up.
There was no effect of condition on the cognitive tar-
gets (see Table S2 in the Supplemental Material). For the 
SST (n = 125), there was a main effect of time, F(1, 123) = 
30.13, p < .001, which indicated a decrease in scores from 
baseline to posttreatment, but not condition, F(1, 121) < 1, 
and there was no significant Time × Condition interaction, 
F(1, 123) < 1, d = 0.02, 95% CI = [–0.33, 0.38]. For PIT posi-
tive vividness (n = 115), there was no significant differ-
ence in change from baseline to posttreatment between 
the two conditions, t(113) = 1.49, p = .14, d = 0.28. In the 
overall mixed model, there was a main effect of time, F(4, 
113) = 5.29, p = .001, thereby indicating an increase in 
vividness scores over time, and no main effect of condi-
tion, F(1, 110.97) = 1.50, p = .22. The overall interaction of 
condition and time was nonsignificant, F(4, 113) < 1.
Clinically significant change. For the intention-to-
treat sample, 17.1%, 95% CI = [10.2, 27.3], of participants in 
the imagery condition and 21.6% [13.7, 32.4] in the control 
condition demonstrated clinically significant change (as 
defined by our recovery criteria) at posttreatment. By 
6-month follow-up, these figures were 36.8% [26.9, 48.1] 
and 31.1% [21.7, 42.4], respectively. For the per-protocol 
sample, 18.6% [10.6, 30.6] of participants in the imagery 
condition and 21.4% [12.6, 34.0] of those in the control 
condition demonstrated clinically significant change at 
posttreatment. By 6-month follow-up, these figures were 
40.7% [29.1, 53.5] and 35.7% [24.5, 48.9], respectively.
Satisfaction ratings. Participant ratings at 6-month 
follow-up were significantly higher in the imagery condi-
tion than in the control condition—satisfaction: Mimagery = 
4.79, SD = 1.32 vs. Mcontrol = 3.89, SD = 1.57, t(122) = 3.47, 
p = .001, d = 0.62; confidence in recommending to a 
friend: Mimagery = 5.24, SD = 1.31 vs. Mcontrol = 3.84, SD = 
1.79, t(122) = 4.97, p < .001, d = 0.89; willingness to try 
again: Mimagery = 5.55, SD = 1.72 vs. Mcontrol = 4.55, SD = 
2.16, t(122) = 2.85, p = .005, d = 0.51.
Why did we not find the expected 
superiority of the imagery condition 
in our main efficacy analyses?
After the unexpected finding that there was no difference 
in outcomes between the imagery and control conditions 
in our main efficacy analyses, we carried out further 
exploratory analyses to test subsequent hypotheses about 
why we might not have obtained the expected results. 
Given that these hypotheses were concerned with mech-
anisms by which the interventions may or may not have 
led to change rather than broader efficacy questions, we 
used the per-protocol sample for these analyses unless 
otherwise specified.
Did the imagery condition have a specific effect on 
anhedonia? Although the imagery CBM did not lead to 
greater improvement than the control condition on the 
whole constellation of depressive symptoms (as mea-
sured by the BDI-II, which includes cognitive, affective, 
and somatic symptoms), it may have a more specific 
effect on aspects of depressive symptoms that were more 
closely matched to what was practiced in the training 
itself, that is, imagining oneself enjoying or taking interest 
in activities. We therefore investigated whether imagery 
CBM could have led to increased enjoyment or interest in 
activities in day-to-day life, that is, decreased anhedonia. 
We found that there was a significantly greater reduction 
in anhedonia in participants in the imagery condition 
compared with the control condition from baseline to 
posttreatment, t(113.18) = 2.17, p = .032, d = 0.41, 95% 
CI = [0.04, 0.78], although this was not consistently main-
tained over all follow-up time points, as indicated by a 
nonsignificant Time × Condition interaction in the overall 
mixed model fitted over all five time points, F(4, 112.42) = 
1.67, p = .16 (see Fig. 2). The mixed model showed a 
main effect of time, F(4, 112.42) = 26.64, p < .001, which 
indicated a decrease in anhedonia over the study time 
points, and a main effect of condition, F(1, 111.48) = 6.67, 
p = .011, thereby indicating that on average across the 
five time points, anhedonia scores were lower in the 
imagery condition compared with the control condition 
(see Table S1 in the Supplemental Material).
Did the imagery condition only lead to superior 
outcomes in a subgroup of our clinically heteroge-
neous sample? We next investigated the possibility 
that imagery CBM exerted a beneficial effect in specific 
subgroups of the broad range of depressed patients 
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recruited to our trial. The subgroups examined were 
guided by the CBM and depression treatment literature 
and defined using both a measure of illness recurrence 
(number of episodes of depression) and the stratifica-
tion variables employed in the study (gender, baseline 
depression severity). Evidence for moderation was indi-
cated by a significant three-way interaction (Time × 
Condition × Subgroup) in the mixed model (with BDI-II 
as dependent measure).
In terms of illness recurrence, our sample was charac-
terized by a high number of episodes of depression. We 
found a significant moderating effect of number of epi-
sodes of depression, F(4, 111) = 2.99, p = .022, with our 
sample split at the midpoint into participants with fewer 
than five (n = 55) versus those with five or more (n = 60) 
depressive episodes. This corresponds to the cutoff in the 
trial by Bockting et al. (2005), whose sample had similar 
levels of recurrence and medication use to ours. Within 
the subgroup with fewer than five depressive episodes, 
there was a significantly greater reduction in BDI-II from 
baseline to posttreatment in the imagery condition com-
pared with the control condition, t(53) = 2.66, p = .01, d = 
0.73, 95% CI = [0.19, 1.28]. For the overall mixed model, 
the Time × Condition interaction was significant, F(4, 53) = 
2.60, p = .047 (see Fig. 2). Investigation of this interaction 
across the assessment time points revealed that the reduc-
tion in symptoms of depression from baseline was signifi-
cantly greater in participants in the imagery condition 
compared with the control condition at 1-month follow-
up, t(53) = 2.66, p = .01, d = 0.73, 95% CI = [0.18, 1.28], but 
no longer at 3-month follow-up, t(53) = 1.70, p = .10, d = 
0.47, 95% CI = [–0.07, 1.00] (see Table S1 in the Supplemental 
Material). The mixed model also showed a main effect of 
time, F(4, 53) = 15.51, p < .001, but not of condition, F(1, 
53) = 1.35, p = .25. Within the subgroup with five or more 
depressive episodes, there was no difference between the 
conditions in reduction in BDI-II from baseline to post-
treatment, t(58) < 1, and no Time × Condition interaction 
in the overall mixed model, F(4, 58) = 1.06, p = .39. There 
was a main effect of time, F(4, 58) = 20.68, p < .001, but 
not of condition, F(1, 57.67) < 1.
We found no evidence of moderation for our stratifica-
tion variables (baseline BDI-II category, gender; cf. 
Blackwell & Holmes, 2010; Lang et al., 2012) or for age 
(cf. Blackwell & Holmes, 2010), current antidepressant 
use (e.g., Browning et al., 2011), baseline bias (SST; cf. 
Micco, Henin, & Hirschfeld-Becker, 2014), or question-
naire-measured imagery ability (PIT positive vividness, 
SUIS; cf. Lang et al., 2012).
Was the imagery intervention helpful only for those 
participants who successfully engaged with imag-
ery? We next investigated whether engaging with a 
putative active component of the imagery CBM—vividly 
imagining the training scenarios—was necessary for par-
ticipants to benefit from the imagery condition.
Within the imagery condition, we carried out the same 
mixed-model analysis as for the main efficacy analyses, 
with BDI-II as outcome, but included the mean vividness 
rating (M = 3.42, SD = 0.71) as a covariate. A significant 
Time × Vividness interaction, F(4, 57) = 3.66, p = .010, 
indicated that the more vividly participants in the imag-
ery condition imagined the training scenarios during the 
4-week intervention, the greater their reduction in symp-
toms of depression during the course of the study.
In fact, the same moderating effect of imagery was 
found when vividness ratings from participants’ very first 
attempt at the task (first block of the practice session, i.e., 
eight scenarios; M = 3.59, SD = 0.71) were considered—
Interaction × Time: F(4, 62.17) = 2.98, p = .026—using all 
participants in the imagery condition for whom these 
data were available (n = 72; the data did not save cor-
rectly for 4 participants). This suggests that it may be 
possible to estimate the likely impact of the imagery 
training on participants’ depression on the basis of only 
an initial eight-scenario assessment of the ease with 
which they engage in the task and before these ratings 
could be influenced by improvement in depression.
Within the control condition, there was no evidence 
for a relationship between difficulty ratings and reduction 
in BDI-II, as indicated by a nonsignificant Time × 
Difficulty interaction, F(4, 54) < 1, in an equivalent mixed-
model analysis that included the mean difficulty rating 
(M = 1.55, SD = 0.60) as a covariate.
We investigated what level of imagery vividness was 
required for participants in the imagery condition, com-
pared with those in the control condition, to experience a 
greater reduction in symptoms of depression from base-
line to posttreatment. A regression within the imagery 
condition (dependent variable: change in BDI-II from 
baseline to posttreatment; independent variable: mean 
vividness score) indicated that a mean vividness of more 
than 3.52 (where 3 = somewhat vivid and 4 = very vivid) 
was required in order for the reduction in BDI-II to be 
greater than the upper bound (95% CI) of the mean 
decrease within the control condition of 8.84, correspond-
ing to 27 participants or 45.8% of our per-protocol sam-
ple. This result is illustrated in Figure 2c, which plots the 
change in score on the BDI-II in the subgroup of partici-
pants in the imagery condition who reached this “vivid-
ness threshold” against the change in the control condition 
for comparison (estimated marginal means are derived 
from a mixed model analysis using this subsample).
Was the reduction in symptoms of depression 
related to changes in the cognitive targets? Given 
that there was no significant difference between condi-
tions in change in cognitive targets from baseline to 
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posttreatment, as assessed by either SST negativity or PIT 
positive vividness, we collapsed scores across both con-
ditions to investigate the relationship between cognitive 
targets and symptoms of depression.3 At baseline, BDI-II 
correlated significantly with SST negativity, r(115) = .51, 
p < .001, but there was a nonsignificant trend with PIT 
positive vividness, r(115) = –.16, p = .09. Reduction in 
BDI-II from baseline to posttreatment correlated signifi-
cantly with both reduction in SST negativity, r(113) = .46, 
p < .001, and increase in PIT positive vividness, r(115) = 
.39, p < .001. We carried out a regression with baseline 
BDI-II and change in both SST negativity and PIT posi-
tive vividness from baseline to posttreatment as predic-
tors and change in BDI-II from baseline to posttreatment 
as dependent variables. Change in both SST negativity 
(β = 0.35, p < .001) and PIT positive vividness (β = 0.28, 
p = .001) independently predicted reduction in BDI-II. 
We investigated whether bias at posttreatment was pre-
dictive of future depression. When we controlled for 
BDI-II posttreatment, SST negativity posttreatment was 
not correlated with BDI-II at 1-month follow-up, r(110) = 
.14, p = .15, but was correlated significantly with BDI-II 
at 3-month follow-up, r(110) = .22, p = .019, and at 
6-month follow-up, r(110) = .22, p = .02. PIT positive 
vividness at posttreatment was not correlated signifi-
cantly with BDI-II at any follow-up time point.
Discussion
We carried out an RCT in which 150 participants with cur-
rent major depression were assigned to a 4-week imagery 
CBM or an active control condition, delivered via the 
Internet, and assessed up to 6-months posttreatment. 
There was a high completion rate for the Internet-delivered 
CBM, and participant feedback was positive. In our 
planned analyses, we did not find the expected superiority 
of the imagery CBM over the control condition in reducing 
symptoms of depression (our primary outcome measure), 
reducing negative interpretive bias, or increasing vividness 
of positive future imagery. Participants in both conditions 
showed equal improvements on all these measures.
However, exploratory post hoc analyses revealed that 
participants in the imagery CBM condition experienced a 
greater improvement in anhedonia (a subgroup of 
depressive symptoms related to the loss of interest in or 
enjoyment from activities) over the intervention com-
pared with those in the control condition. Furthermore, 
within the subgroup of participants with fewer than five 
episodes of depression, there was a significantly greater 
reduction in symptoms of depression as a whole in the 
imagery CBM condition compared with the control con-
dition. Finally, we found that the more vividly partici-
pants in the imagery CBM condition reported imagining 
the training scenarios during the intervention, the more 
their symptoms of depression reduced. Participants in the 
imagery CBM condition who engaged to a threshold 
level of imagery vividness experienced a greater reduc-
tion in symptoms of depression as a whole than did par-
ticipants in the control condition. Vividness ratings in just 
the initial practice session also predicted subsequent 
reduction in symptoms of depression. These results from 
the trial highlight potentially fruitful pathways for further 
development of imagery CBM as a low-intensity treat-
ment tool in the context of depression.
In reflecting on the results of the current study, it is 
worth noting some points of RCT methodology, as the 
majority of CBM research has taken place within the con-
text of experimental studies. The close adherence to a 
clinical trials framework is a strength of the current study 
(Kiluk et  al., 2011). We had a sufficiently large sample, 
with good adherence rates and data coverage, to provide 
robust estimates of effect sizes and also a relatively “real-
world” sample, for example, with many previous depres-
sive episodes and concurrent comorbidities. We carried 
out face-to-face diagnostic assessments with all partici-
pants and, thus, have a well-characterized sample, which 
is often not possible with Internet RCTs (Andersson & 
Titov, 2014). However, it is also worth noting that in using 
relatively broad inclusion criteria, rather than the more 
restrictive criteria often used in efficacy RCTs (e.g., von 
Wolff et al., 2014), we obtained a comparatively heteroge-
neous sample, which may have increased the variance 
and decreased the signal-to-noise ratio in comparison 
with standard efficacy RCTs. For example, we did not 
exclude participants from analysis on the basis of depres-
sion severity or suicidality.
Prior to the present trial, our experimental studies in 
nonclinical samples had demonstrated increased positive 
affect as an outcome of imagery CBM, compared with a 
control condition (Holmes, Coughtrey, & Connor, 2008; 
Holmes et al., 2006; Holmes, Lang, & Shah, 2009; Nelis 
et  al., 2012; Pictet et  al., 2011; Rohrbacher, Blackwell, 
Holmes, & Reinecke, 2014). Consistent with these prior 
results, exploratory post hoc analyses of the present 
results revealed a significantly greater reduction in anhe-
donia over the 4-week intervention in the imagery CBM 
condition compared with the control condition. Anhedonia 
is a core symptom of depression that is relatively resistant 
to current first-line therapies but is predictive of poorer 
treatment outcomes (Treadway & Zald, 2011; Uher et al., 
2012) and is recognized as an important but neglected 
clinical target in its own right (e.g., Insel, 2012). Although, 
in the current study, we did not find the expected 
between-groups difference for reduction in symptoms of 
depression as a whole, the indication that imagery CBM 
may contribute to reducing anhedonia is worth pursuing, 
as neither current psychological nor current pharmaco-
logical treatments are adequate in this regard.
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Our exploratory post hoc finding that the imagery 
CBM was more effective than the control condition in 
reducing symptoms of depression among participants 
with fewer than five episodes of depression (albeit not in 
the full sample) suggests that the positive imagery aspect 
of the intervention may be more useful for individuals 
whose depression is less recurrent. This contrasts with 
psychological treatment studies that target relapse pre-
vention, which have tended to find greater usefulness for 
people with more (rather than fewer) episodes of depres-
sion (e.g., Bockting et  al., 2005; Teasdale et  al., 2000). 
However, this subgroup analysis in our RCT was not 
specified prior to the trial, and clearly this finding needs 
replication. A future trial could include number of depres-
sive episodes as a stratification variable with a planned 
subgroup analysis (Sun et al., 2012). Were a precise num-
ber of depressive episodes to be of interest, a structured 
assessment, such as a timeline (e.g., Crane et al., 2014), 
may be useful.
The more vividly participants reported imagining the 
positive training scenarios during the imagery CBM, the 
more their symptoms of depression were reduced. Vividly 
imagining the training scenarios is thought to be an active 
ingredient in the effects of the imagery CBM. Several pre-
vious studies (Holmes, Coughtrey, & Connor, 2008; 
Holmes et al., 2006; Holmes, Lang, & Shah, 2009; Nelis 
et  al., 2012; Torkan et  al., 2014) have shown that only 
when participants were instructed specifically to imagine 
the positive training scenarios (e.g., as opposed to pro-
cessing the information verbally) did they show positive 
changes in mood and cognitive bias. Our current vivid-
ness findings suggest that in the measurement of adher-
ence to computerized interventions (cf. Kiluk et al., 2011), 
it is important to include measures of “active” adherence 
(i.e., engaging with the intervention; here, vividness of 
imagery) rather than simply “passive” adherence (e.g., 
going through the motions of completing sessions; cf. 
Bendelin et al., 2011, in relation to iCBT).
Vividness ratings made for just the first eight training 
scenarios in the initial practice session of the imagery 
CBM were predictive of reduction in symptoms of depres-
sion. This makes it unlikely that enhanced vividness was 
a secondary consequence of symptom improvement 
rather than being an active agent. If so, it seems impor-
tant in future research to identify people who may need 
further training in imagery prior to starting the interven-
tion (cf. Lang et al., 2012; Steel et al., 2010).
The critical question remaining is that of why the main 
primary outcome analyses of BDI-II scores failed to 
reveal any differences between groups. It may be that 
neither the imagery CBM condition nor the control con-
dition had any beneficial effects on depression overall or, 
alternatively, that both conditions were equally effective. 
In the absence of a no-intervention (e.g., wait list) 
control, we have no direct evidence that the change in 
symptoms of depression was any greater than in the 
absence of any intervention. In recent meta-analyses, 
Cuijpers et  al. (2012) reported a pre- to posttreatment 
effect size (g) of 0.39, 95% CI = [0.03, 0.74], in waiting-list/
care-as-usual groups, and Rutherford, Mori, Sneed, 
Pimontel, and Roose (2012) reported an effect size (d) of 
0.51 [0.27, 0.74] over wait lists with a mean duration of 10 
weeks. Lack of overlap between these CIs and those for 
the within-groups effect sizes in our imagery condition 
(and limited overlap for the control condition) during a 
similar time period (1-month follow-up: dimagery = 1.16, 
[0.85, 1.48], dcontrol = 0.90, [0.61, 1.20]; 3-month follow-up: 
dimagery = 1.15, [0.81, 1.49], dcontrol = 0.92, [0.60, 1.24]) sug-
gests that greater change occurred in the current trial 
than would be expected during the same time with no 
intervention. The within-groups effect sizes in the current 
RCT are in the same range as those reported for change in 
symptoms of depression from pre- to posttreatment in tri-
als of Internet-delivered psychological therapies for 
depression, with Cohen’s ds of 1.35, 0.95, and 0.78 for 
therapist-supported, administrative-supported, and unsup-
ported therapies, respectively (Richards & Richardson, 
2012). However, any inferences from these indirect com-
parisons can be regarded only as hypotheses for testing in 
future studies.
Even if it is granted that both groups showed some 
improvement, it remains unclear why there were no differ-
ences in BDI-II change between the imagery CBM condi-
tion and the control condition. Our previous experimental 
studies all found differences between groups assigned to 
similar interventions and control conditions (Holmes, 
Coughtrey, & Connor, 2008; Holmes et al., 2006; Holmes, 
Lang, & Shah, 2009; Nelis et al., 2012; Rohrbacher et al., 
2014), including those with clinical samples (Lang et al., 
2012; Torkan et al., 2014; Williams et al., 2013). However, 
these previous studies also showed a differential effect of 
imagery CBM versus the control condition on cognitive 
targets (e.g., measures of bias), which we assume is the 
mechanism driving mood change. In the current trial, we 
did not find differential change in cognitive targets between 
conditions; thus, differential effects on symptom outcomes 
may not be expected (Clarke, Notebaert, & MacLeod, 
2014). Symptom change was related to the extent of 
change in cognitive targets, although measurement of 
these at only pre- and posttreatment limits attributions of 
causality (Kraemer, Wilson, Fairburn, & Agras, 2002; 
Mogoaşe, David, & Koster, 2014). Comparison of the 
within-groups effect sizes for BDI-II change in the current 
RCT with those from studies investigating a 1-week imag-
ery CBM intervention (Blackwell & Holmes, 2010; Lang 
et al., 2012; Torkan et al., 2014; Williams et al., 2013) sug-
gests that we obtained both less improvement than 
expected in the imagery condition and more improvement 
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than expected in the control condition. There are a num-
ber of differences between the previous studies and the 
current RCT that may account for this unexpected 
finding.
The current study was conducted within a clinical- trials 
framework, including prospective registration, indepen-
dent randomization and robust allocation concealment, 
intention-to-treat principles for our main analyses, and 
blinding of outcome assessors (Moher et al., 2010). This 
was not the case for previous studies in which, for exam-
ple, the outcome assessors were not blind to participant 
allocation, thereby potentially allowing for more demand 
effects. Furthermore, a clinical trial may attract different 
participants, with different expectancies and experiences, 
which can have an impact on outcomes and the ability to 
detect between-groups effects (cf. Rutherford & Roose, 
2013). From this perspective, it is possible that we were 
overoptimistic in our expectation of a medium between-
groups effect size and that anticipation of a small 
between-groups effect size (as we found in the current 
per-protocol analysis for the BDI-II) would have been 
more realistic. Given the low-intensity nature of the inter-
vention (the median session duration was just less than 
20 min, which means that for most people, the 12-session 
intervention came to less than 4 hr in total), a small 
between-groups effect size may in fact still reflect a cost-
effective intervention technique and, thus, be worth pur-
suing. However, the sample size required to have 
adequate power to detect such an effect (N = 788 for 80% 
power at 5% significance level) was beyond the scope of 
this initial trial.
The current study also differed from previous research 
in the duration, schedule, and location of the active inter-
vention. It may be that the more an intervention moves 
from the confines of tightly controlled laboratory ses-
sions, the more the individual variation in adherence to 
the intended manipulation and, thus, the smaller any 
between-groups effects will become. Furthermore, it is 
possible that most of the within-session learning happens 
in the early sessions and, thus, an increase in the number 
of sessions and the length of the schedule (as in the cur-
rent trial) leads to diminishing returns (cf. Eberl et  al., 
2014; Stafford & Dewar, 2014).
Conversely, our control condition may have benefitted 
by the extension of the training schedule. This condition 
may have contained some of the active components of 
the intervention, for example, the exposure to ambigu-
ous information (which theoretically may activate the 
potential competing meanings; cf. Clarke, Nanthakumar, 
et al., 2014; Mathews, 2012) and the experience of this 
ambiguity being resolved, both positively and negatively, 
which may enhance cognitive flexibility (anticipation that 
either outcome is possible). From the experimental single-
session literature, one might expect a control condition 
with no imagery instructions and no valence-specific 
training contingency to exert little impact on cognitive 
bias during a single session and, thus, be considered 
“inert.” However, factors having no impact within single-
session studies, such as reflective processes that take 
more time to consolidate and exert effects, may gain in 
importance during longer periods. Clinical translation of 
CBM could benefit from moving beyond regarding CBM 
interventions as simply repeated instances of single ses-
sions and considering more broadly the mechanisms by 
which differential engagement in the intervention could 
influence clinical outcomes (cf. Blackwell & Holmes, 
2010; Standage, Harris, & Fox, 2014).
A major limitation of the current study is the lack of a 
no-intervention (e.g., wait list) control; thus, we do not 
have direct evidence that the change observed in our 
participants was more than would have been observed in 
the absence of any intervention. However, a broader per-
spective of the psychological treatment field suggests that 
simply finding another psychological treatment with 
superior efficacy to a wait list may not be the optimal 
solution. Numerous treatments that are better than a wait 
list (Cuijpers, van Straten, Bohlmeijer, Hollon, & 
Andersson, 2010) already exist, and it has been argued 
that psychological treatment development could benefit 
from moving away from a reliance on wait list controls 
and instead carrying out more rigorous tests against 
appropriately matched control conditions (Boot, Simons, 
Stothart, & Stutts, 2013; Furukawa et al., 2014), as in CBM 
studies (Clarke, Notebaert, & MacLeod, 2014). However, 
CBM researchers may benefit from consideration of 
whether a control condition used in an experimental 
study to isolate one specific mechanism is always the 
most useful control condition for a trial aimed at estab-
lishing clinical efficacy. The development of control con-
ditions that are similar to the placebos used in 
pharmacological trials, as in superficially resembling the 
intervention but containing none of its active ingredients 
(as may have occurred here), may be a useful way 
forward.
Our choice of primary outcome—depressive symp-
toms as measured by the BDI-II—was broad. An inter-
vention may target a specific process very effectively, but 
if success is evaluated primarily via a broader measure of 
disorder, this could lead to underestimation of its effec-
tiveness (Reardon, 2014). In the case of positive imagery 
CBM, the underlying cognitive model (i.e., repeated sim-
ulation of positive outcomes; Holmes, Lang, & Deeprose, 
2009) and current findings suggest that in future studies, 
a measure of anhedonia may be worth exploring as a 
more specific primary outcome measure (rather than 
depressive symptoms as a whole). It would be useful to 
include separate measures of anhedonia in addition to 
that provided by BDI-II (Davidson et al., 2010).
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In conclusion, our findings are in one sense negative: 
They did not support the proposal that positive imagery 
CBM is an effective treatment for depression. However, 
there is also some suggestion from exploratory analyses 
that imagery CBM may have potential as a technique to 
improve anhedonia or to help individuals with less recur-
rent depression or those who engage to a threshold level 
of imagery. We consider each of these possibilities in the 
following paragraphs. It is worth noting that the field of 
CBM is young and currently in the early stages of clinical 
translation (Clarke, Notebaert, & MacLeod, 2014; Fox, 
Mackintosh, & Holmes, 2014). An unexpected result, as 
in the current RCT, can be informative in a variety of 
ways, as we have discussed. For example, there may be 
wider implications for the field concerning the choice of 
control condition or of outcome measurement in moving 
from the lab to the clinic.
In future work, researchers should seek to explore 
and extend implications of the current RCT. Various 
methodological options are worthy of consideration. A 
brief “run-in” phase for adherence to the treatment 
requirements (i.e., to engage to a threshold level of imag-
ery) might be used prior to randomization—a strategy 
beginning to be used in some pharmacological RCTs 
(Geddes et  al., 2010). The training itself could also be 
refined. Specifically, we suggest the need for evaluation 
of improved versions of imagery CBM suitable for real-
world (rather than lab) training environments. For exam-
ple, participants may be guided to achieve higher 
standards of vivid positive self-referent imagery prior to 
entry into the main phase of the intervention and main-
tain this during the course of the intervention via feed-
back processes.
Such improved imagery CBM versions would need to 
be evaluated in comparison with different types of con-
trol conditions that are more convincingly inert in the 
longer term (e.g., by avoiding any emotional material, or 
without resolving ambiguity either positively or nega-
tively). Nonetheless, the apparent improvement seen in 
the present control condition raises interesting questions 
about idiosyncratic ways in which participants may 
engage with training delivered via the Internet. The com-
mon practice of using equal frequencies of negative and 
positive resolutions of ambiguity as a control condition in 
CBM may require reconsideration when used in more 
prolonged interventions, and the potential benefit of 
inducing a more flexible emotional response style needs 
to be further evaluated.
The results of the current RCT suggest that the effi-
cacy of imagery CBM within a sample of depressed indi-
viduals with few prior episodes of depression should be 
investigated. In fact, within the general population, a 
slight majority of patients with major depression may fall 
below the split point in the current study of five 
episodes, given that the median number of lifetime 
depressive episodes is four ( Judd, 1997). In a heteroge-
neous disorder such as depression, identifying particular 
subgroups of patients for whom an intervention may be 
particularly helpful, or patient stratification, is an impor-
tant part of treatment development (Kazdin & Blase, 
2011).
The potential for imagery CBM to improve anhedonia, 
as indicated in the current RCT, should be followed up, 
given that this core symptom of depression poses a major 
challenge to current treatments (Insel, 2012; Treadway & 
Zald, 2011). A useful first step may be to better character-
ize the effects of imagery CBM by using richer measures of 
anhedonia that relate to its various facets (e.g., anticipation 
vs. experience of pleasure; Dunn, 2012; Pizzagalli, 2014). 
If it is indeed the case that imagery CBM can improve 
anhedonia, then it may have particular value as an adjunct 
to current treatment approaches (psychological or phar-
macological) that improve other symptoms of depression 
while leaving anhedonia relatively untouched. An experi-
mental psychopathology approach could be used to inves-
tigate whether imagery CBM and treatment approaches 
such as iCBT or antidepressants do in fact work via com-
plementary mechanisms, given that treatments often do 
not combine in an additive manner (Browning et al., 2011). 
Overall, a consideration of outcome measures, alongside 
refined methodology as discussed earlier, would allow 
researchers to assess whether the preliminary indications 
of benefit seen here can be replicated.
Appendix
Trial sites and approvals
The trial was sponsored by the University of Oxford. 
Research and development approval was obtained from 
Oxfordshire Primary Care Trust and Oxford Health NHS 
Foundation Trust to act as participant identification cen-
ters. All recruitment and face-to-face assessment proce-
dures took place at the main research site, the Department 
of Psychiatry, University of Oxford. In April 2013, the 
MRC Cognition and Brain Sciences Unit, Cambridge, was 
added as a subsidiary site for remote collection of remain-
ing follow-up data and for conducting data analyses. The 
relevant management approvals were obtained for both 
sites.
Randomization
Randomization took place at the baseline assessment 
after completion of all baseline questionnaire measures. 
Participants were randomized in a 1:1 ratio to one of two 
groups, imagery cognitive bias modification or control, 
within the constraints of stratification by gender and 
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baseline Beck Depression Inventory–II score (mild-to-
moderate score of 28 or less vs. severe score of 29 or 
more). The researcher who carried out the baseline 
assessment assigned participants to their allocated inter-
vention via a Web-based randomization system written 
by the clinical trials software development team in the 
Oxford Cognitive Health and Neurosciences Clinical 
Trials Unit and hosted by the University of Oxford 
Medical Sciences Information Management Unit. 
Randomization was carried out using a secret allocation 
table, generated by the University of Oxford Centre for 
Statistics in Medicine, with a variable-length block struc-
ture to ensure that allocations were balanced and could 
not be predicted by trial staff.
Blinding
Blinding of participants to allocation was achieved by 
having only those aspects of the study interventions that 
were common to both conditions (e.g., schedule of ses-
sions and general nature of tasks, such as listening to 
scenarios, responding to pictures) in the study informa-
tion. Participants were debriefed about the nature of the 
two different study conditions at the end of the trial (once 
they had completed the 6-month outcome measures) 
and, thus, did not know the specifics of the other condi-
tion until they had finished the trial. In the face-to-face 
posttreatment assessment, a researcher blind to partici-
pant allocation was assigned to administer the outcome 
questionnaires, and blinding was achieved for at least the 
primary outcome with one exception (due to an admin-
istrative oversight). Thus, the trial can be considered 
“double blind.”
The trial database was maintained as blind until all 
data collection, checking, and cleaning for the main effi-
cacy analyses had taken place; after this, participant con-
dition was downloaded from the randomization service 
and inserted into the database. Initial data checking and 
cleaning was carried out by S.E.B. and research assistants 
involved in data collection, and a random selection of 
10% of baseline and posttreatment data were then addi-
tionally checked by another researcher not otherwise 
involved in the study and blind to participant condition.
Participant contact during the 
intervention
Contact from the researchers during the 4-week interven-
tion included e-mails (Mimagery = 18.95, SD = 3.77; Mcontrol = 
18.14, SD = 3.24), t(148) = 1.41, p = .16; phone calls 
(Mimagery = 0.33, SD = 0.93; Mcontrol = 0.24, SD = 0.57), 
t(148) = 0.68, p = .50; and voice mail messages (Mimagery = 
0.18, SD = 0.58; Mcontrol = 0.07, SD = 0.30), t(148) = 1.53, 
p = .13.
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Notes
1. That is, corresponding to the primary outcome measure as 
prespecified in the clinical trials registration. Following recom-
mendations for RCTs (Moher et al., 2010), we prespecified one 
measure as the primary outcome measure in our trial protocol 
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and registration and powered the RCT accordingly. In taking 
the step from previous smaller-scale studies to the current RCT, 
we decided to preserve the same outcome measure (Beck 
Depression Inventory–II) for which we had found change in 
these earlier studies.
2. Effect sizes for change from baseline within conditions, 
expressed as Cohen’s ds, were calculated as the mean change 
from baseline estimated from the mixed model divided by 
the standard deviation (raw score) at baseline. Effect sizes 
for the difference in change from baseline between condi-
tions, expressed as Cohen’s ds, were calculated using the t and 
degree-of-freedom values for the relevant fixed-effect estimates 
derived from the mixed model by using the d = 2t/sqrt(df) 
formula (Rosenthal & Rosnow, 1991). CIs for d values were cal-
culated via the formulae provided by Viechtbauer (2007) using 
estimated parameters from the mixed model. CIs for propor-
tions were calculated via the modified Wald method (Agresti & 
Coull, 1998).
3. There was no difference between conditions in the relation-
ship between change in these cognitive targets and change in 
scores on the BDI-II. Two participants within the BDI-II per-
protocol sample did not complete the SST at posttreatment.
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